MANE
Veradermics, Incorporated
NYSE · Healthcare · Biotechnology · US
$98.51
+0.78%Aug 11, 2026, 11:30 UTC
Veradermics reported its financial results for the second quarter ended June 30, 2026.
Source:Jul 15, 2026, 17:47 UTC
Veradermics Incorporated released topline results from an open-label Phase 2 trial of its experimental oral hair loss drug VDPHL01 in women with mild-to-moderate pattern hair loss.